F-star Therapeutics, Inc.

FSTX · NASDAQ
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$31-$26-$23-$23
Dep. & Amort.$1$1$1$0
Deferred Tax-$0$0$4-$0
Stock-Based Comp.$7$3$3$3
Change in WC-$5$1-$9$0
Other Non-Cash$2$3$2-$5
Operating Cash Flow-$27-$16-$22-$25
Investing Activities
PP&E Inv.-$1-$1-$0-$2
Net Acquisitions$0$0$5$0
Inv. Purchases$0$0-$15-$58
Inv. Sales/Matur.$0$5$39$35
Other Inv. Act.$0$10-$24$0
Investing Cash Flow-$1$14$5-$25
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$78$15$0$38
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$88$16$13$41
Financing Cash Flow$88$16$13$41
Forex Effect-$0-$0$0$0
Net Chg. in Cash$60$14-$3-$9
Supplemental Information
Beg. Cash$19$5$8$24
End Cash$79$19$5$15
Free Cash Flow-$28-$17-$22-$27
F-star Therapeutics, Inc. (FSTX) Financial Statements & Key Stats | AlphaPilot